| The epidemiology of multimorbidity in primary care: a retrospective cohort study A Cassell, D Edwards, A Harshfield, K Rhodes, J Brimicombe, R Payne, ... British Journal of General Practice 68 (669), e245-e251, 2018 | 494 | 2018 |
| Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data KM Rhodes, RM Turner, JPT Higgins Journal of clinical epidemiology 68 (1), 52-60, 2015 | 349 | 2015 |
| Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study J Browne, DA Edwards, KM Rhodes, DJ Brimicombe, RA Payne BMJ open 7 (3), e012546, 2017 | 163 | 2017 |
| Two new methods to fit models for network meta-analysis with random inconsistency effects M Law, D Jackson, R Turner, K Rhodes, W Viechtbauer BMC medical research methodology 16, 1-14, 2016 | 53 | 2016 |
| Empirical evidence about inconsistency among studies in a pair-wise meta-analysis KM Rhodes, RM Turner, JPT Higgins Research Synthesis Methods, 2015 | 52 | 2015 |
| Methods for calculating confidence and credible intervals for the residual between-study variance in random effects meta-regression models D Jackson, R Turner, K Rhodes, W Viechtbauer BMC Medical Research Methodology 14, 1-12, 2014 | 47 | 2014 |
| Implementing informative priors for heterogeneity in meta‐analysis using meta‐regression and pseudo data KM Rhodes, RM Turner, IR White, D Jackson, DJ Spiegelhalter, J Higgins Statistics in Medicine 35 (29), 5495-5511, 2016 | 45 | 2016 |
| De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma L Masterson, D Moualed, A Masood, RC Dwivedi, R Benson, JC Sterling, ... Cochrane Database of Systematic Reviews, 2014 | 42 | 2014 |
| Between-trial heterogeneity in meta-analyses may be partially explained by reported design characteristics KM Rhodes, RM Turner, J Savović, HE Jones, D Mawdsley, JPT Higgins Journal of clinical epidemiology 95, 45-54, 2018 | 40 | 2018 |
| Incorporating external evidence on between‐trial heterogeneity in network meta‐analysis RM Turner, CP Domínguez‐Islas, D Jackson, KM Rhodes, IR White Statistics in medicine 38 (8), 1321-1335, 2019 | 24 | 2019 |
| Alternative weighting schemes when performing matching‐adjusted indirect comparisons D Jackson, K Rhodes, M Ouwens Research Synthesis Methods 12 (3), 333-346, 2021 | 22 | 2021 |
| Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly … I Vergote, I Ray-Coquard, DM Anderson, G Cantuaria, N Colombo, ... European Journal of Cancer 157, 415-423, 2021 | 21 | 2021 |
| Correlation between early endpoints and overall survival in non-small-cell lung cancer: A trial-level meta-analysis K Shameer, Y Zhang, D Jackson, K Rhodes, IKA Neelufer, S Nampally, ... Frontiers in Oncology 11, 672916, 2021 | 19 | 2021 |
| Population adjusted indirect comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 studies of olaparib with or without bevacizumab, bev alone and placebo in the maintenance treatment … IB Vergote, KN Moore, R Hettle, K Rhodes, M Ouwens, I Ray-Coquard Gynecologic Oncology 159, 19-20, 2020 | 17 | 2020 |
| Adjusting trial results for biases in meta-analysis: combining data-based evidence on bias with detailed trial assessment KM Rhodes, J Savović, R Elbers, HE Jones, JPT Higgins, JAC Sterne, ... Journal of the Royal Statistical Society Series A: Statistics in Society 183 …, 2020 | 14 | 2020 |
| EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies C Nordon, K Rhodes, JK Quint, CF Vogelmeier, SO Simons, NM Hawkins, ... BMJ open 13 (4), e070022, 2023 | 12 | 2023 |
| Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease NM Hawkins, C Nordon, K Rhodes, M Talukdar, S McMullen, P Ekwaru, ... Heart, 2024 | 10 | 2024 |
| Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study. EL Graul, C Nordon, K Rhodes, J Marshall, S Menon, C Kallis, ... American Journal of Respiratory & Critical Care Medicine 209 (8), 2024 | 9 | 2024 |
| Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study EL Graul, C Nordon, K Rhodes, J Marshall, S Menon, C Kallis, ... American Journal of Respiratory and Critical Care Medicine 209 (8), 960-972, 2024 | 9 | 2024 |
| Increased risk of severe cardiovascular events following exacerbations of COPD: a multi-database cohort study C Vogelmeier, S Simons, E Garbe, D Sin, N Hawkins, N Manito, S Santos, ... European Respiratory Journal 62 (suppl 67), 2023 | 9 | 2023 |
Rebecca TurnerMRC Clinical Trials Unit at UCLE-mailová adresa ověřena na: ucl.ac.uk
